Akebia Therapeutics, Inc. reports $26.2 million Q1 loss
The company generated $40.10 million in quarterly revenue
By USInMinutes
Published - May 08, 2023, 09:26 AM ET
Last Updated - Jul 18, 2023, 03:34 PM EDT
Akebia Therapeutics, Inc. [AKBA] has reported fiscal Q1 loss of $26.20 million.
On a per-share basis, the DE based company said its diluted earnings are $0.14.
The Pharmaceutical Preparations firm posted revenue of $40.10 million in this period.
Also Read:
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
